Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-25-066067
Filing Date
2025-07-07
Accepted
2025-07-07 16:01:28
Documents
5
Period of Report
2025-08-05

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2519277-2_def14a.htm DEF 14A 298047
2 GRAPHIC lg_carismatherapeutics-4c.jpg GRAPHIC 45021
3 GRAPHIC sg_stevenkelly-bw.jpg GRAPHIC 4735
4 GRAPHIC px_25carismaproxy1pg01-4c.jpg GRAPHIC 263156
5 GRAPHIC px_25carismaproxy1pg02-4c.jpg GRAPHIC 260937
  Complete submission text file 0001104659-25-066067.txt   1033865
Mailing Address 3675 MARKET STREET SUITE 401 PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET SUITE 401 PHILADELPHIA PA 19104 2674916422
Carisma Therapeutics Inc. (Filer) CIK: 0001485003 (see all company filings)

EIN.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36296 | Film No.: 251107938
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)